Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...

Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care.

Six-year-old Bentley’s diagnosis of precursor B cell acute lymphocytic leukemia (B-ALL) in 2019 sent his family into a ...

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...

Mutational signatures etched into the cells' genome by an anti-cancer drug called temozolomide (TMZ) uncover an Achilles' heel for TMZ chemotherapy resistance, according to new research.

Pharmacist Ayesha Gulza has revealed 11 of the common medications that can trigger the uncomfortable sensation known as ...

California-based Apollomics had been testing uproleselan as an adjunct to chemotherapy in relapsed and refractory acute ...

GSK's combined drugs Jemperli and Zejula met its primary goal of progression-free survival in patients with first line advanced ovarian cancer in a late-stage trial.

GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...

A 2023 shortage of the generic platinum-based chemotherapy drugs cisplatin and carboplatin had no effect on cancer mortality rates, according to a study published Dec. 3 in the Journal of the National ...

Cancer patients undergoing chemotherapy in New York will now have greater access to hair-preservation treatments, thanks to ...